cytomegaloviru cm infect increasingly recon critic ill immunocompet patient studi demons assoc disease increase mortal rate prolong intent care unit host length stay meghan until nosocomi infect howe consider controversy whether metres causal relationship favor outcome marker sever critic ill detect use polymerase chain reaction antigenemia standard diagnose approach may variety clinic manifest reflect involve differ organ system treatment challenge due challenge drug toxic build predict model set would promise identify risk start prophylact therapy object broadly review current literature prevail rcid potent limit modal prognosis therapeutic option 